Differential effects of kinase inhibitors on erythropoietin and vascular endothelial growth factor gene expression in rat hepatocytes
β Scribed by Bernhard Gess; Peter Sandner; Armin Kurtz
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 872 KB
- Volume
- 432
- Category
- Article
- ISSN
- 0031-6768
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The effect of tyrosine kinase inhibitor, erbstatin, on cell growth and mRNA expression of growth-factor/receptor system was examined in 6 human gastric-carcinoma cell lines. Erbstatin inhibited both EGF-induced and serum-stimulated cell growth of all 6 cell lines (TMK-I, MKN-I, -7, -28, -45, -74) in
## Abstract This study investigated the role of vascular endothelial growth factor (VEGF) in the neoangiogenesis induced in heart in response to hypoxia. The timeβcourse of adaptive changes in capillary supply, expression of VEGF mRNA and protein was studied in right (RV) and left ventricles (LV) o
## Abstract ## Background: Several researchers have observed that cyclooxygenaseβ2 (COXβ2) inhibitors display anticancer effects only at higher concentrations than doses that block COXβ2 activity in head and neck squamous cell carcinoma (HNSCC) cells. ## Methods: To better understand the exact a
## Abstract OST cells, a low metastatic cell line established from human osteosarcoma, were inoculated under the periosteum of the ossa cranii of nude mice. Four weeks later, tumors were percutaneously treated for an additional 4 weeks with a patch containing either placebo or ketoprofen (KP). In t